Influenza Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for influenza diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Influenza Diagnostics Market Size (2024E): USD 1.8 Billion
Projected Market Value (2033F): USD 3.0 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 6.1%

Influenza Diagnostics Market - Report Scope:

Influenza diagnostics play a crucial role in the early detection, treatment, and management of influenza infections. These diagnostics include rapid influenza diagnostic tests (RIDTs), reverse transcription-polymerase chain reaction (RT-PCR) assays, and other molecular diagnostic tools. The market serves hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of diagnostic devices that provide timely and accurate results to manage influenza outbreaks effectively.

Market growth is driven by increasing prevalence of influenza, rising healthcare expenditures, and advancements in diagnostic technology, enhancing detection accuracy and reducing diagnostic time.

Market Growth Drivers:

The global influenza diagnostics market is propelled by several key factors, including growing awareness about early diagnosis and treatment of influenza to prevent complications and transmission. The rising incidence of influenza infections, coupled with the demand for effective diagnostic solutions during seasonal outbreaks, further drives market expansion. Technological advancements, such as the development of highly sensitive and specific molecular diagnostic tools, offer improved detection rates and shorter turnaround times, fostering market growth. Moreover, the increasing adoption of point-of-care testing and home-based diagnostic solutions creates new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the influenza diagnostics market faces challenges related to regulatory compliance, reimbursement policies, and competition from alternative diagnostic methods. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for diagnostic tests and the high cost of advanced diagnostic equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to accurate and affordable diagnostic solutions.

Market Opportunities:

The influenza diagnostics market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of diagnostics beyond influenza, including in the detection of other respiratory viruses and infections, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic diagnostics landscape.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the influenza diagnostics market globally?
Which diagnostic types and applications are driving influenza diagnosis across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the influenza diagnostics market?
Who are the key players contributing to the influenza diagnostics market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global influenza diagnostics market?

Competitive Intelligence and Business Strategy:

Leading players in the global influenza diagnostics market, including Roche Diagnostics, Abbott Laboratories, and Quidel Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular assays and point-of-care tests, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving diagnostics landscape.

Key Companies Profiled:

Abbott Laboratories
Endress+Hauser (Analytik Jena AG)
Becton, Dickinson and Company
Biocartis
bioMerieux Inc
Danaher Corporation (Cepheid)
F. Hoffmann-La Roche Ltd
GenMark Diagnostics, Inc.
Luminex Corporation
Meridian Bioscience, Inc
Quidel Corporation
Thermo Fisher Scientific Inc.
Hologic

Key Segments Covered in Influenza Diagnostics Industry Research

Test:

Molecular Diagnostic Test
Traditional Diagnostic Test

Type of Flu:

Type A Flu
Type B Flu
Type C Flu

End User:

Hospitals
Diagnostic Laboratories
Research & Academic Institute
Contract Research Organization (CRO's)

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Product Code: PMRREP13246

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic and Promotional Strategies
4.4. Key Regulations
4.5. Disease Epidemiology
4.6. PESTLE Analysis
4.7. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Market Outlook
- 5.1.3. Global Infectious Disease Diagnostics Market Overview
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Top Influenza Diagnostics Companies & their Historical Growth
- 5.2.2. Application Innovation in Influenza Diagnostics
- 5.2.3. Product Adoption Rate
- 5.2.4. Regulatory Impositions
- 5.2.5. Growing R&D Investments
- 5.2.6. Novel Diagnostic Product Development Activities
- 5.2.7. Awareness Campaigns for Influenza Diagnostics
5.3. Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Test
- 6.1.2. By Type of Flu
- 6.1.3. By End User
6.2. 2024 Market Scenario

7. Global Influenza Diagnostics Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Test

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Test, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Test, 2024-2033
- 8.3.1. Molecular Diagnostics Tests
  - 8.3.1.1. RT-PCR
  - 8.3.1.2. LAMP
  - 8.3.1.3. NASABA
- 8.3.2. Traditional Diagnostics Tests
  - 8.3.2.1. Rapid Influenza Detection Kits
  - 8.3.2.2. Serological Assays
  - 8.3.2.3. Direct Fluorescent Antibody
  - 8.3.2.4. Viral Culture
  - 8.3.2.5. H1N1 Influenza A Virus Identification Kits
  - 8.3.2.6. Immunoassay Kits
  - 8.3.2.7. Immunofluorescence Antibody Assay
8.4. Market Attractiveness Analysis By Test

9. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Type of Flu

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Type of Flu, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type of Flu, 2024-2033
- 9.3.1. Type A Flu
- 9.3.2. Type B Flu
- 9.3.3. Type C Flu
9.4. Market Attractiveness Analysis By Type of Flu

10. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by End User

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
- 10.3.1. Hospitals
- 10.3.2. Diagnostic Laboratories
- 10.3.3. Research & Academic Institutes
- 10.3.4. Contract Research Organizations (CRO)
10.4. Market Attractiveness Analysis By End User

11. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by Region

11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. South Asia
- 11.3.5. East Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Test
- 12.3.3. By Type of Flu
- 12.3.4. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Test
- 12.4.3. By Type of Flu
- 12.4.4. By End User
12.5. Country Level Analysis & Forecast
- 12.5.1. U.S. Influenza Diagnostics Market Analysis
  - 12.5.1.1. Introduction
  - 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.1.2.1. By Test
    - 12.5.1.2.2. By Type of Flu
    - 12.5.1.2.3. By End User
- 12.5.2. Canada Influenza Diagnostics Market Analysis
  - 12.5.2.1. Introduction
  - 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.2.2.1. By Test
    - 12.5.2.2.2. By Type of Flu
    - 12.5.2.2.3. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
12.9. Country Level Analysis & Forecast

13. Latin America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Brazil
  - 13.3.1.2. Mexico
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
- 13.3.2. By Test
- 13.3.3. By Type of Flu
- 13.3.4. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Test
- 13.4.3. By Type of Flu
- 13.4.4. By End User
13.5. Country Level Analysis & Forecast
- 13.5.1. Brazil Influenza Diagnostics Market Analysis
  - 13.5.1.1. Introduction
  - 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.1.2.1. By Test
    - 13.5.1.2.2. By Type of Flu
    - 13.5.1.2.3. By End User
- 13.5.2. Mexico Influenza Diagnostics Market Analysis
  - 13.5.2.1. Introduction
  - 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.2.2.1. By Test
    - 13.5.2.2.2. By Type of Flu
    - 13.5.2.2.3. By End User
- 13.5.3. Argentina Influenza Diagnostics Market Analysis
  - 13.5.3.1. Introduction
  - 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.3.2.1. By Test
    - 13.5.3.2.2. By Type of Flu
    - 13.5.3.2.3. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
13.9. Country Level Analysis & Forecast

14. Europe Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. France
  - 14.3.1.3. Italy
  - 14.3.1.4. U.K.
  - 14.3.1.5. Spain
  - 14.3.1.6. Russia
  - 14.3.1.7. BENELUX
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Test
- 14.3.3. By Type of Flu
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Test
- 14.4.3. By Type of Flu
- 14.4.4. By End User
14.5. Country Level Analysis & Forecast
- 14.5.1. Germany Influenza Diagnostics Market Analysis
  - 14.5.1.1. Introduction
  - 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.1.2.1. By Test
    - 14.5.1.2.2. By Type of Flu
    - 14.5.1.2.3. By End User
- 14.5.2. France Influenza Diagnostics Market Analysis
  - 14.5.2.1. Introduction
  - 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.2.2.1. By Test
    - 14.5.2.2.2. By Type of Flu
    - 14.5.2.2.3. By End User
- 14.5.3. Italy Influenza Diagnostics Market Analysis
  - 14.5.3.1. Introduction
  - 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.3.2.1. By Test
    - 14.5.3.2.2. By Type of Flu
    - 14.5.3.2.3. By End User
- 14.5.4. U.K. Influenza Diagnostics Market Analysis
  - 14.5.4.1. Introduction
  - 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.4.2.1. By Test
    - 14.5.4.2.2. By Type of Flu
    - 14.5.4.2.3. By End User
- 14.5.5. Spain Influenza Diagnostics Market Analysis
  - 14.5.5.1. Introduction
  - 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.5.2.1. By Test
    - 14.5.5.2.2. By Type of Flu
    - 14.5.5.2.3. By End User
- 14.5.6. Russia Influenza Diagnostics Market Analysis
  - 14.5.6.1. Introduction
  - 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.6.2.1. By Test
    - 14.5.6.2.2. By Type of Flu
    - 14.5.6.2.3. By End User
- 14.5.7. BENELUX Influenza Diagnostics Market Analysis
  - 14.5.7.1. Introduction
  - 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.7.2.1. By Test
    - 14.5.7.2.2. By Type of Flu
    - 14.5.7.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast

15. South Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. India
  - 15.3.1.2. Thailand
  - 15.3.1.3. Indonesia
  - 15.3.1.4. Malaysia
  - 15.3.1.5. Rest of South Asia
- 15.3.2. By Test
- 15.3.3. By Type of Flu
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Test
- 15.4.3. By Type of Flu
- 15.4.4. By End User
15.5. Country Level Analysis & Forecast
- 15.5.1. India Influenza Diagnostics Market Analysis
  - 15.5.1.1. Introduction
  - 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.1.2.1. By Test
    - 15.5.1.2.2. By Type of Flu
    - 15.5.1.2.3. By End User
- 15.5.2. Thailand Influenza Diagnostics Market Analysis
  - 15.5.2.1. Introduction
  - 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.2.2.1. By Test
    - 15.5.2.2.2. By Type of Flu
    - 15.5.2.2.3. By End User
- 15.5.3. Indonesia Influenza Diagnostics Market Analysis
  - 15.5.3.1. Introduction
  - 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.3.2.1. By Test
    - 15.5.3.2.2. By Type of Flu
    - 15.5.3.2.3. By End User
- 15.5.4. Malaysia Influenza Diagnostics Market Analysis
  - 15.5.4.1. Introduction
  - 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.4.2.1. By Test
    - 15.5.4.2.2. By Type of Flu
    - 15.5.4.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast

16. East Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. China
  - 16.3.1.2. Japan
  - 16.3.1.3. South Korea
- 16.3.2. By Test
- 16.3.3. By Type of Flu
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Test
- 16.4.3. By Type of Flu
- 16.4.4. By End User
16.5. Country Level Analysis & Forecast
- 16.5.1. China Influenza Diagnostics Market Analysis
  - 16.5.1.1. Introduction
  - 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.1.2.1. By Test
    - 16.5.1.2.2. By Type of Flu
    - 16.5.1.2.3. By End User
- 16.5.2. Japan Influenza Diagnostics Market Analysis
  - 16.5.2.1. Introduction
  - 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.2.2.1. By Test
    - 16.5.2.2.2. By Type of Flu
    - 16.5.2.2.3. By End User
- 16.5.3. South Korea Influenza Diagnostics Market Analysis
  - 16.5.3.1. Introduction
  - 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.3.2.1. By Test
    - 16.5.3.2.2. By Type of Flu
    - 16.5.3.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast

17. Oceania Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Test
- 17.3.3. By Type of Flu
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Test
- 17.4.3. By Type of Flu
- 17.4.4. By End User
17.5. Country Level Analysis & Forecast
- 17.5.1. Australia Influenza Diagnostics Market Analysis
  - 17.5.1.1. Introduction
  - 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.1.2.1. By Test
    - 17.5.1.2.2. By Type of Flu
    - 17.5.1.2.3. By End User
- 17.5.2. New Zealand Influenza Diagnostics Market Analysis
  - 17.5.2.1. Introduction
  - 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.2.2.1. By Test
    - 17.5.2.2.2. By Type of Flu
    - 17.5.2.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast

18. Middle East and Africa Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkey
  - 18.3.1.3. South Africa
  - 18.3.1.4. North Africa
  - 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Test
- 18.3.3. By Type of Flu
- 18.3.4. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Test
- 18.4.3. By Type of Flu
- 18.4.4. By End User
18.5. Country Level Analysis & Forecast
- 18.5.1. GCC Countries Influenza Diagnostics Market Analysis
  - 18.5.1.1. Introduction
  - 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.5.1.2.1. By Test
    - 18.5.1.2.2. By Type of Flu
    - 18.5.1.2.3. By End User
- 18.5.2. Turkey Influenza Diagnostics Market Analysis
  - 18.5.2.1. Introduction
  - 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.5.2.2.1. By Test
    - 18.5.2.2.2. By Type of Flu
    - 18.5.2.2.3. By End User
- 18.5.3. South Africa Influenza Diagnostics Market Analysis
  - 18.5.3.1. Introduction
  - 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.5.3.2.1. By Test
    - 18.5.3.2.2. By Type of Flu
    - 18.5.3.2.3. By End User
- 18.5.4. North Africa Influenza Diagnostics Market Analysis
  - 18.5.4.1. Introduction
  - 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.5.4.2.1. By Test
    - 18.5.4.2.2. By Type of Flu
    - 18.5.4.2.3. By End User
18.6. Drivers and Restraints - Impact Analysis
18.7. Market Trends
18.8. Key Market Participants - Intensity Mapping
18.9. Country Level Analysis & Forecast

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Concentration
19.4. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Deep Dive
- 20.2.1. Abbott Laboratories
  - 20.2.1.1. Overview
  - 20.2.1.2. Product Portfolio
  - 20.2.1.3. Key Financials
  - 20.2.1.4. Sales Footprint
  - 20.2.1.5. Strategy Overview
    - 20.2.1.5.1. Marketing Strategy
    - 20.2.1.5.2. Product Strategy
    - 20.2.1.5.3. Channel Strategy
- 20.2.2. Endress+Hauser (Analytik Jena AG)
  - 20.2.2.1. Overview
  - 20.2.2.2. Product Portfolio
  - 20.2.2.3. Key Financials
  - 20.2.2.4. Sales Footprint
  - 20.2.2.5. Strategy Overview
    - 20.2.2.5.1. Marketing Strategy
    - 20.2.2.5.2. Product Strategy
    - 20.2.2.5.3. Channel Strategy
- 20.2.3. Becton, Dickinson and Company
  - 20.2.3.1. Overview
  - 20.2.3.2. Product Portfolio
  - 20.2.3.3. Key Financials
  - 20.2.3.4. Sales Footprint
  - 20.2.3.5. Strategy Overview
    - 20.2.3.5.1. Marketing Strategy
    - 20.2.3.5.2. Product Strategy
    - 20.2.3.5.3. Channel Strategy
- 20.2.4. Biocartis
  - 20.2.4.1. Overview
  - 20.2.4.2. Product Portfolio
  - 20.2.4.3. Key Financials
  - 20.2.4.4. Sales Footprint
  - 20.2.4.5. Strategy Overview
    - 20.2.4.5.1. Marketing Strategy
    - 20.2.4.5.2. Product Strategy
    - 20.2.4.5.3. Channel Strategy
- 20.2.5. bioMerieux Inc
  - 20.2.5.1. Overview
  - 20.2.5.2. Product Portfolio
  - 20.2.5.3. Key Financials
  - 20.2.5.4. Sales Footprint
  - 20.2.5.5. Strategy Overview
    - 20.2.5.5.1. Marketing Strategy
    - 20.2.5.5.2. Product Strategy
    - 20.2.5.5.3. Channel Strategy
- 20.2.6. Danaher Corporation (Cepheid)
  - 20.2.6.1. Overview
  - 20.2.6.2. Product Portfolio
  - 20.2.6.3. Key Financials
  - 20.2.6.4. Sales Footprint
  - 20.2.6.5. Strategy Overview
    - 20.2.6.5.1. Marketing Strategy
    - 20.2.6.5.2. Product Strategy
    - 20.2.6.5.3. Channel Strategy
- 20.2.7. F. Hoffmann-La Roche Ltd
  - 20.2.7.1. Overview
  - 20.2.7.2. Product Portfolio
  - 20.2.7.3. Key Financials
  - 20.2.7.4. Sales Footprint
  - 20.2.7.5. Strategy Overview
    - 20.2.7.5.1. Marketing Strategy
    - 20.2.7.5.2. Product Strategy
    - 20.2.7.5.3. Channel Strategy
- 20.2.8. GenMark Diagnostics, Inc.
  - 20.2.8.1. Overview
  - 20.2.8.2. Product Portfolio
  - 20.2.8.3. Key Financials
  - 20.2.8.4. Sales Footprint
  - 20.2.8.5. Strategy Overview
    - 20.2.8.5.1. Marketing Strategy
    - 20.2.8.5.2. Product Strategy
    - 20.2.8.5.3. Channel Strategy
- 20.2.9. Luminex Corporation
  - 20.2.9.1. Overview
  - 20.2.9.2. Product Portfolio
  - 20.2.9.3. Key Financials
  - 20.2.9.4. Sales Footprint
  - 20.2.9.5. Strategy Overview
    - 20.2.9.5.1. Marketing Strategy
    - 20.2.9.5.2. Product Strategy
    - 20.2.9.5.3. Channel Strategy
- 20.2.10. Meridian Bioscience, Inc
  - 20.2.10.1. Overview
  - 20.2.10.2. Product Portfolio
  - 20.2.10.3. Key Financials
  - 20.2.10.4. Sales Footprint
  - 20.2.10.5. Strategy Overview
    - 20.2.10.5.1. Marketing Strategy
    - 20.2.10.5.2. Product Strategy
    - 20.2.10.5.3. Channel Strategy
- 20.2.11. Quidel Corporation
  - 20.2.11.1. Overview
  - 20.2.11.2. Product Portfolio
  - 20.2.11.3. Key Financials
  - 20.2.11.4. Sales Footprint
  - 20.2.11.5. Strategy Overview
    - 20.2.11.5.1. Marketing Strategy
    - 20.2.11.5.2. Product Strategy
    - 20.2.11.5.3. Channel Strategy
- 20.2.12. Thermo Fisher Scientific Inc.
  - 20.2.12.1. Overview
  - 20.2.12.2. Product Portfolio
  - 20.2.12.3. Key Financials
  - 20.2.12.4. Sales Footprint
  - 20.2.12.5. Strategy Overview
    - 20.2.12.5.1. Marketing Strategy
    - 20.2.12.5.2. Product Strategy
    - 20.2.12.5.3. Channel Strategy
- 20.2.13. Hologic
  - 20.2.13.1. Overview
  - 20.2.13.2. Product Portfolio
  - 20.2.13.3. Key Financials
  - 20.2.13.4. Sales Footprint
  - 20.2.13.5. Strategy Overview
    - 20.2.13.5.1. Marketing Strategy
    - 20.2.13.5.2. Product Strategy
    - 20.2.13.5.3. Channel Strategy